Global N95 Masks Market - Trends, Key Players, Market Analysis, and Forecast till 2031

<h2>Demand for N95 Masks from 2015 to 2020 Vs Future Market Projections for 2021-2031</h2>
From 2015 to 2020, sales of N95 Masks were high, expanding at under 4.1% CAGR.

With the sudden outbreak of COVID-19 in China's Wuhan province on 11 March 2020, the World Health Organization (WHO) declared the Novel Coronavirus Disease (COVID-19) outbreak as a pandemic ramped up the demand and sales of N95 Masks.

N95 respirators and surgical masks are essential parts of personal protective equipment used to protect the wearer from numerous airborne particles. The rising demand from frontline healthcare workers and the general population for N95 Masks is expected to grow the target market. The Centers for Disease Control and Prevention (CDC), National Institute for Occupational Safety and Health (NIOSH), and the Occupational Safety and Health Administration (OSHA) also recommend the usage of N95 marks during this pandemic situation.

<strong>Global N95 Masks Market Revenue Outlook:</strong>

The global N95 masks market was valued at US$ 3.5 Bn in 2020 and is projected to register а СÐGR of 6.0% by 2031.

Nonetheless, various industry players in the global N95 masks market are now increasing their focus towards the establishment of successful collaborations, acquisitions, and joint venture activities as a means to enhance their respective customer bases. These players are also increasing their supply capabilities to meet customer requirements on a local and global scale. This factor, paired with promising industrialization prospects in developing economies of the Asia-Pacific region, such as China, India, Taiwan, Indonesia, etc., are expected to create massive business opportunities for key players over the forecast period.

<strong>How is demand for masks increasing N95 Masks sales?</strong>

An increasing number of cases caused by bacteria, viruses, fungi, or parasites, including Diphtheria, Ebola, Flu (Influenza), and others, has been noted recently. The growing prevalence of COVID-19 worldwide has increased the demand for N95 Masks designed to protect the mouth and nose from foreign biological infectious particles.

<strong>Some Major Funding for Coronavirus</strong>

<strong>The US funding for Coronavirus</strong>

The US has sanctioned an US$ 8.3 billion fund to fight the recent virus outbreak of COVID-19. This is a significantly huge amount compared to the funding budget allocated for other diseases, such as US$ 5.4 billion allocated for Ebola and US$ 7 billion for the H1N1 virus by the US health regulatory authority.

<strong>UK's funding for Coronavirus</strong>

Recently appointed UK Chancellor Rishi Sunak has made a US$ 35.49 billion budget to protect the country's economy from the adverse effects of the coronavirus pandemic. This budget aims to offer the most considerable boost to public investments for several generations to drive long-term growth.

<strong>Regional Development Mission for Asia</strong>

The Asian countries received a funding of US$ 800,000 for laboratory systems, case finding, surveillance, technical assistance, risk communications, prevent and control infection in health facilities

The World Bank Group is the largest donor of committed funds for COVID-19, announcing upwards of US$12 billion in immediate support for the country's response. Japan is the second-largest donor, devoting most of its US$1.6 billion in COVID-19 funding to the World Health Organization's COVID-19 response. The European Union and International Bank for Reconstruction and Development (IRBD) came together in third place with US$1.5 billion committed funds coming from each.

<strong>What Are The Key Challenges To Market Expansion For Manufacturers Of N95 Masks?</strong>

A significant challenge expected to hamper sales of N95 Masks is the rules and regulations differ from country to country, and the regulatory environment is ever-changing due to increasing development costs and times and market pressures impacting medical devices and the pharmaceutical sector. The differences in the regulations of different countries are driven by numerous economic, legal, or political factors, thus limiting market growth.

Low availability and sub-standard quality of non-medical facemasks in several countries for reducing the transmission and infectivity of COVID-2019 is expected to hamper the growth of the global N95 masks market. However, certain players are attempting to expand their business ...

<h2>2015年至2020年N95口罩需求与2021-2031年未来市场预测对比</h2>
在2015年至2020年期间，N95口罩的销售额保持高位，年复合增长率低于4.1%。

2020年3月11日，中国武汉市突发COVID-19疫情，世界卫生组织（WHO）宣布新型冠状病毒疾病（COVID-19）大流行，这一事件激增了对N95口罩的需求和销售额。

N95呼吸器和外科口罩是个人防护装备的重要组成部分，用于保护佩戴者免受多种空气传播颗粒的侵害。预计来自一线医疗工作者和普通大众对N95口罩的需求增长将扩大目标市场。疾病控制与预防中心（CDC）、国家职业安全与健康研究院（NIOSH）和职业安全与健康管理局（OSHA）也推荐在疫情期间使用N95口罩。

<strong>全球N95口罩市场收入展望：</strong>
2020年，全球N95口罩市场规模达到35亿美元，预计到2031年将实现6.0%的年复合增长率。

尽管如此，全球N95口罩市场的众多参与者正在增加对成功合作、收购和合资经营活动的关注，以此作为扩大各自客户群的手段。这些参与者也在提高其供应能力，以满足本地和全球范围内的客户需求。这一因素，加上亚太地区（如中国、印度、台湾、印度尼西亚等）发展中经济体工业化的前景，预计将为关键玩家在预测期内创造巨大的商业机会。

<strong>口罩需求如何推动N95口罩销售额增长？</strong>
近期已注意到由于细菌、病毒、真菌或寄生虫引起的病例数量增加，包括白喉、埃博拉、流感（流行性感冒）等。全球范围内COVID-19的日益流行增加了旨在保护口鼻免受外来生物感染颗粒的N95口罩的需求。

<strong>针对冠状病毒的一些主要资金投入</strong>

<strong>美国的冠状病毒资金</strong>
美国已拨款83亿美元用于抗击最近爆发的COVID-19病毒疫情。与分配给其他疾病（如美国卫生监管机构分配的54亿美元用于埃博拉病毒和70亿美元用于H1N1病毒）的资金预算相比，这是一个巨大的数额。

<strong>英国对冠状病毒的资金投入</strong>
最近任命的英国财政大臣里希·苏纳克为保护国家经济免受冠状病毒大流行的不利影响，拨款354.9亿美元预算。该预算旨在为几代人以来的公共投资提供最大的提振，以推动长期增长。

<strong>亚洲地区发展使命</strong>
亚洲各国获得了800万美元的资金用于实验室系统、病例发现、监测、技术援助、风险沟通、在医疗机构预防和控制感染。
世界银行集团是COVID-19承诺资金的最大捐助者，宣布为国家的应对措施提供超过120亿美元的即时支持。日本是第二大捐助者，将其16亿美元的COVID-19资金的大部分捐给了世界卫生组织的COVID-19应对措施。欧盟和国际复兴开发银行（IRBD）并列第三，各自承诺了15亿美元的资金。

<strong>制造N95口罩的制造商在市场扩张中面临哪些关键挑战？</strong>
预期将阻碍N95口罩销售的显著挑战是各国法规不同，且由于成本和时间的增加以及医疗器械和制药行业的市场压力，监管环境不断变化。不同国家法规的差异是由众多经济、法律或政治因素驱动的，从而限制了市场增长。
预计一些国家非医用口罩的低可用性和低质量将阻碍全球N95口罩市场的增长。然而，某些参与者正在尝试扩大其业务范围...